# INOVIO PHARMACEUTICALS, INC. stock analysis

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses SynCon, to help engineer precisely designed plasmid DNA plasmids, as well as CELLECTRA smart devices technology that

## Market evidence and data freshness

The public preview recorded INOVIO PHARMACEUTICALS, INC. at 1.443 USD on 2026-11-05T18:57:03.000Z and marked the quote as delayed. This observation is not a trading signal.
Available price history spans 2025-09-24 through 2026-11-03 across 280 observations; the listed source is CommonQuant Parquet archive backed by Yahoo Finance delayed data. The history end date differs from the latest quote date.

## What should I review before buying INOVIO PHARMACEUTICALS, INC. stock?

Compare valuation with reported financial performance, inspect the price history, and weigh the evidence for and against the investment case. Review the risks and assumptions before making your own decision.

## Inside the full report

- Valuation
- Growth
- Financial health
- Ownership
- Research

Sign in to open the full analysis. Paid plans use included reports first, then your weekly usage limit. Access lasts 72 hours, including revisits.

[Read the report](https://commonquant.ai/markets/ino)